Jennifer Levin Carter - Director at Insight Molecular Diagnostics Inc.

Issuer-level insider activity

Role
Director
Issuer ticker
IMDX on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Jennifer Levin Carter since 17 Aug 2025

Reported holdings for Jennifer Levin Carter in Insight Molecular Diagnostics Inc.

Form 4 holding Director

Oncocyte Corp

Security class
Common Stock, no par value
Shares / value
30,500
Estimated value
$6,554
Report date
16 Aug 2022
Price
$0.2149
Ownership
Direct
Form 4 holding Director

Oncocyte Corp

Security class
Option to Purchase Common Stock
Shares / value
45,000
Estimated value
Report date
15 Aug 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Jennifer Levin Carter in Insight Molecular Diagnostics Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .